Crystal Adam Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$5.14M

Insider Activity of Crystal Adam

According to the SEC Form 4 filings, Crystal Adam, being in a position of

  1. President, R&D at Tango Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 332508 shares for $6.99M,
    over all time since 2023-11-01, has bought 0 shares, and sold 362669 shares for $7.2M.

Biography of Crystal Adam

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$6,989,37112100

Comparison of Insiders on Amount of Buys and Sells

2026-10-01SaleTango Therapeutics, Inc.
TNGX
President, R&D
27,000
0.018%
$24.47$660,796-7.08%
2026-09-01SaleTango Therapeutics, Inc.
TNGX
President, R&D
27,000
0.0166%
$22.37$603,909+4.21%
2026-08-03SaleTango Therapeutics, Inc.
TNGX
President, R&D
27,000
0.0188%
$27.24$735,517-12.5%
2026-07-01SaleTango Therapeutics, Inc.
TNGX
President, R&D
27,000
0.0223%
$29.59$798,908-14.27%
2026-06-01SaleTango Therapeutics, Inc.
TNGX
President, R&D
27,000
0.023%
$22.87$617,571+9.46%
2026-05-01SaleTango Therapeutics, Inc.
TNGX
President, R&D
27,000
0.0235%
$21.23$573,097+16.9%
2026-04-15SaleTango Therapeutics, Inc.
TNGX
President, R&D
38,460
0.0327%
$25.00$961,500-2.01%
2026-04-01SaleTango Therapeutics, Inc.
TNGX
President, R&D
27,000
0.0232%
$21.20$572,478+15.5%
2026-03-25SaleTango Therapeutics, Inc.
TNGX
President, R&D
12,000
0.0099%
$20.11$241,320+17.03%
2026-03-05SaleTango Therapeutics, Inc.
TNGX
President, R&D
20,251
0.0163%
$15.00$303,765+41.92%
2026-02-25SaleTango Therapeutics, Inc.
TNGX
President, R&D
54,345
0.0498%
$12.77$694,208+87.65%
2026-02-03SaleTango Therapeutics, Inc.
TNGX
President, R&D
18,452
0.0163%
$12.26$226,300+86.22%
2025-02-05SaleTango Therapeutics, Inc.
TNGX
See Remarks
6,851
0.0066%
$3.16$21,659+100%
2025-02-04SaleTango Therapeutics, Inc.
TNGX
See Remarks
7,432
0.0071%
$2.99$22,207+119.74%
2024-02-07SaleTango Therapeutics, Inc.
TNGX
See Remarks
4,083
0.0042%
$12.62$51,527-40.57%
2024-02-06SaleTango Therapeutics, Inc.
TNGX
See Remarks
4,288
0.0044%
$12.56$53,868-40.38%
2023-11-01SaleTango Therapeutics, Inc.
TNGX
See Remarks
7,507
0.0075%
$8.39$62,994+4.93%
2022-01-04SaleC4 Therapeutics, Inc.
CCCC
Chief Medical Officer
30,000
0.0617%
$31.66$949,935-69.95%
2021-10-01SaleC4 Therapeutics, Inc.
CCCC
Chief Medical Officer
30,000
0.0644%
$45.43$1.36M-54.31%
2021-07-29SaleC4 Therapeutics, Inc.
CCCC
Chief Medical Officer
30,000
0.0354%
$24.99$749,700-42.91%
Total: 22
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.